XIDX
MBTO
Market cap12mUSD
Nov 12, Last price
192.00IDR
Name
Martina Berto Tbk PT
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Martina Berto Tbk, together with its subsidiaries, manufactures and sells cosmetics and herbal medicines in Indonesia and internationally. The company operates in two segments, Cosmetics and Herbal. Its liquid cosmetics include face cleansing liquids, moisturizers, toners, foundations, body splash colognes, and hair sprays; dry cosmetics comprising eye shadows, blush on products, and loose and compact powders; semi slid cosmetics, such as lipsticks, creamy foundations, and others; and herbal products, including traditional face maskers, body scrubs, and herbal teas. The company is also involved in marketing and trading cosmetics, beauty care products, and herbal medicines. In addition, it engages in contract manufacturing of private labels for dry cosmetics, semi solid cosmetics, liquid cosmetics, and aerosols. The company markets its products through online stores, chain stores, and supermarkets, as well as through wholesalers, cosmetic retailers, beauty salons, and spas. It sells its products under the Cempaka, Martina, Pesona, Biokos Martha Tilaar, Caring Colours Martha Tilaar, and Belia Martha Tilaar brands. The company was founded in 1977 and is headquartered in Jakarta, Indonesia. PT Martina Berto Tbk is a subsidiary of PT Mathana Megahayu Inti.
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||